Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This summary needs review. Please check the official study record and contact the research team for details.
In CopenhagenThis summary needs review. Please check the official study record and contact the research team for details.
In TucsonThis study is looking at evaluate the efficacy of psilocybin on the symptom of anhedonia in individuals with treatment-resistant major depressive disorder for people with depression, Anhedonia, or Treatment Resistant Depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
In AuroraThis summary needs review. Please check the official study record and contact the research team for details.
In NîmesThis study exists to understand whether psilocybin treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to psilocybin treatment in practice and what may need to be adjusted.
In ChicagoThis summary needs review. Please check the official study record and contact the research team for details.
In San FranciscoThis study is looking at determine the safety, tolerability, and feasibility of psilocybin therapy in people with Bipolarity II. Participants receive a study treatment and complete follow-up visits and assessments.
In San FranciscoThis study is comparing Psilocybin with placebo for people with depression or Addiction. Participants receive Psilocybin or placebo and complete study visits and assessments.
In BaltimoreThis summary needs review. Please check the official study record and contact the research team for details.
In United KingdomThis study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
In Los Angeles
This summary needs review. Please check the official study record and contact the research team for details.
In ChristchurchThis study is looking at see if one or two doses of psilocybin is more effective in relieving depressive symptoms in patients with treatment-resistant depression (TRD) for people with depression or Treatment-Resistant Depression. Participants are followed over time so researchers can learn from clinical and follow-up information.
In TorontoHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.